LAPATINIB DITOSYLATE for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 112 adverse event reports in the FDA FAERS database where LAPATINIB DITOSYLATE was used for Neoplasm malignant.
Most Reported Side Effects for LAPATINIB DITOSYLATE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 893 | 22.6% | 82 | 181 |
| Death | 665 | 16.8% | 664 | 22 |
| Nausea | 317 | 8.0% | 26 | 75 |
| Fatigue | 301 | 7.6% | 28 | 72 |
| Vomiting | 259 | 6.6% | 24 | 97 |
| Rash | 249 | 6.3% | 12 | 36 |
| Drug ineffective | 183 | 4.6% | 14 | 16 |
| Malignant neoplasm progression | 183 | 4.6% | 55 | 47 |
| Off label use | 141 | 3.6% | 3 | 42 |
| Disease progression | 137 | 3.5% | 35 | 22 |
| Palmar-plantar erythrodysaesthesia syndrome | 135 | 3.4% | 16 | 40 |
| Metastases to central nervous system | 132 | 3.3% | 27 | 50 |
| Decreased appetite | 119 | 3.0% | 20 | 35 |
| Dry skin | 119 | 3.0% | 3 | 12 |
| Asthenia | 113 | 2.9% | 20 | 49 |
Other Indications for LAPATINIB DITOSYLATE
Breast cancer (1,219)
Product used for unknown indication (864)
Breast cancer metastatic (531)
Breast cancer female (503)
Her2 positive breast cancer (129)
Her-2 positive breast cancer (62)
Brain neoplasm malignant (42)
Metastatic neoplasm (42)
Metastases to bone (25)
Metastases to central nervous system (23)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)